SJRES 24 is a joint resolution that would block an Environmental Protection Agency (EPA) rule setting new standards for reducing harmful air pollutants from rubber tire manufacturing facilities. If passed, the resolution would prevent the rule - published in the Federal Register on November 29, 2024 - from taking effect, meaning tire manufacturers would not have to comply with the new requirements. The bill directly affects the rubber tire manufacturing industry by removing a specific regulatory obligation. This resolution uses a congressional disapproval process under federal law to stop the EPA rule without creating new regulations.
SRES 95 is a non-binding Senate resolution designating February 23-March 1, 2025, as "National Fentanyl Awareness Week" to highlight the dangers of fentanyl in the U.S. It does not create new laws but encourages public awareness about fentanyl's extreme potency (50x stronger than heroin) and its role in overdose deaths, citing CDC data showing fentanyl-related poisonings as the leading cause of death for U.S. adults aged 18-45. The resolution urges individuals to use only prescribed medications, seek treatment for substance use disorder, and supports law enforcement efforts combating fentanyl trafficking. It directly affects the general public by promoting education and prevention during the designated awareness period.
This bill modifies requirements for pediatric drug studies, particularly for drugs treating rare diseases (orphan drugs). It requires the FDA to issue a noncompliance letter and allow 45 days for response before imposing penalties, and creates an automatic FDA waiver list for diseases where pediatric studies are impractical. Drug sponsors developing orphan drugs for rare conditions will benefit from clearer pathways, as the bill specifies when pediatric studies aren't required unless they offer meaningful therapeutic benefit. The FDA must also report on penalties for noncompliance and update its waiver lists, aiming to streamline development while improving pediatric data for rare diseases.
S 703 (CATCH Fentanyl Act) establishes pilot projects at U.S. border ports to test non-intrusive inspection technologies - such as AI, machine learning, and quantum sensing - to improve detection of contraband, drugs, and threats in cargo and vehicles. The bill requires testing at least five technology types from specified categories, prioritizing those that enhance detection accuracy, reduce wait times, integrate with existing systems, and demonstrate cost-effectiveness. It mandates reports analyzing pilot results, privacy safeguards for data collected during inspections, and recommendations for nationwide implementation, with no new funding authorized. The legislation directly affects U.S. Customs and Border Protection (CBP) at land border ports and aims to modernize inspection processes without altering existing legal frameworks.
The Transportation Freedom Act would create a 200% tax deduction for wages paid to U.S. automobile manufacturing workers who meet specific requirements, including health care coverage and pension benefits. It repeals current emissions standards for light-duty, medium-duty, and heavy-duty vehicles, as well as Corporate Average Fuel Economy (CAFE) standards. The bill establishes new standards for greenhouse gas emissions and fuel economy that must be "technologically feasible and economically practicable," requiring consultation with manufacturers and other stakeholders. It also eliminates existing emissions waivers and creates a process for adjusting standards based on market conditions.
S 717, the *Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025*, expands Medicare coverage for cardiac and pulmonary rehabilitation programs by broadening which healthcare providers can prescribe these services. The bill amends Medicare rules to allow physician assistants, nurse practitioners, and clinical nurse specialists (in addition to physicians) to prescribe exercise and rehabilitation programs under Medicare Part B. This change directly affects Medicare beneficiaries requiring cardiac or pulmonary rehab, making it easier to access care from a wider range of qualified providers. The key provision removes restrictive language limiting prescriptions to "physicians" and updates definitions to include these additional provider types, effective six months after enactment.
This bill requires the U.S. Department of Agriculture (USDA) to join the Committee on Foreign Investment in the United States (CFIUS) for reviews of certain transactions involving foreign adversaries. It specifically targets acquisitions of U.S. agricultural land, biotechnology, or agriculture-related infrastructure (like transportation, storage, or processing) by entities from China, North Korea, Russia, or Iran. The USDA must notify CFIUS about reportable transactions, prompting the committee to determine if a full review is needed. The provisions expire for any country removed from the official list of foreign adversaries in federal regulations.
HR 1575, the "No American Land for Communist China Act," prohibits the People's Republic of China government and businesses with 25% or more Chinese government ownership from purchasing real estate adjacent to specific federal lands. The bill directly affects Chinese government agents and Chinese-affiliated businesses seeking to buy property near lands managed by the Departments of Interior, Defense, Agriculture (Forest Service), and Energy, as well as Indian country. Key provisions require the President to take necessary actions to block such purchases, defining "covered Federal lands" broadly to include national parks, military bases, and tribal lands. The law aims to prevent foreign government influence over land near sensitive U.S. properties through a clear purchase restriction.
This bill defines "sanctuary jurisdiction" as a state or local government that prohibits sharing immigration status information with federal authorities or refuses to comply with federal immigration detainers (requests to hold individuals for immigration enforcement). It makes such jurisdictions ineligible for specific federal grants, including Economic Development Administration funds and Community Development Block Grants, by requiring that grant projects be located in areas not designated as sanctuary jurisdictions. Jurisdictions found to be sanctuary jurisdictions must return any grant funds received during the period they were designated as such and cannot receive future funds until compliance is achieved. The bill takes effect on October 1, 2025.
The Leveling the Playing Field 2.0 Act establishes special rules for handling successive antidumping and countervailing duty investigations, requiring the Department of Commerce to consider prior injury determinations when making new findings. It addresses market distortions from foreign government subsidies and currency undervaluation by expanding how the U.S. calculates fair trade values for imported goods. The bill also creates new procedures to prevent circumvention of existing duties (such as by changing product descriptions to avoid tariffs) and requires importers to certify that merchandise isn't subject to existing duties. These changes primarily affect U.S. Customs and Border Protection, the Department of Commerce, and importers of goods from countries that may be engaging in trade-distorting practices.
New Era of Preventing End-Stage Kidney Disease Act This bill establishes regional centers of excellence, postgraduate fellowships, and training for health professionals relating to the diagnosis and treatment of rare kidney disease. It also requires the Department of Health and Human Services (HHS) to conduct various studies on rare kidney disease. Specifically, it authorizes the National Institute of Diabetes and Digestive and Kidney Diseases to award funding to public and private nonprofit entities for establishing regional centers of excellence that will increase public awareness, conduct research, and develop resources for diagnosing and treating rare kidney diseases. A center may receive such funding for up to five years, unless extended by the institute. The bill also requires health professions schools receiving a grant from the Health Resources and Services Administration (HRSA) Centers of Excellence program to award fellowships for training on preventing, diagnosing, and treating rare kidney disease in disproportionately impacted populations. Also, the bill expands the priorities of HRSA’s Primary Care Training and Enhancement program to include training for health care workers to care for individuals with kidney disease. Additionally, HHS must conduct several studies and report to Congress on topics such as treating rare kidney disease in disproportionately affected populations, eliminating the need for dialysis or kidney transplants, and increasing public awareness of rare kidney disease.
HR 1548, the "Leveling the Playing Field 2.0 Act," amends U.S. trade laws to strengthen enforcement of antidumping and countervailing duty regulations. The bill creates new rules for handling multiple investigations on the same merchandise (successive investigations), addresses market distortions in foreign countries that affect production costs, and improves mechanisms to prevent companies from circumventing existing duties. It also establishes procedures for investigating currency undervaluation as a form of subsidy and strengthens requirements for importers to certify compliance with trade laws. These changes primarily affect U.S. importers of foreign goods, foreign exporters, and the Department of Commerce, which administers these trade enforcement mechanisms.
